287 related articles for article (PubMed ID: 33572915)
1. Expression of Thomsen-Friedenreich Antigen in Colorectal Cancer and Association with Microsatellite Instability.
Leão B; Wen X; Duarte HO; Gullo I; Gonçalves G; Pontes P; Castelli C; Diniz F; Mereiter S; Gomes J; Carneiro F; Reis CA
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572915
[TBL] [Abstract][Full Text] [Related]
2. Relationship Between ABO Blood Group and Microsatellite Instability in Colorectal Cancer: A Retrospective Single-Center Study.
Karaoglan BB; Akyol C; Unal AE; Kuzu A; Savaş B; Utkan G
J Gastrointest Cancer; 2024 Mar; 55(1):281-286. PubMed ID: 37414939
[TBL] [Abstract][Full Text] [Related]
3. The Thomsen-Friedenreich Antigen: A Highly Sensitive and Specific Predictor of Microsatellite Instability in Gastric Cancer.
Mereiter S; Polom K; Williams C; Polonia A; Guergova-Kuras M; Karlsson NG; Roviello F; Magalhães A; Reis CA
J Clin Med; 2018 Sep; 7(9):. PubMed ID: 30189652
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological characteristics of high microsatellite instability/mismatch repair-deficient colorectal cancer: A narrative review.
Mei WJ; Mi M; Qian J; Xiao N; Yuan Y; Ding PR
Front Immunol; 2022; 13():1019582. PubMed ID: 36618386
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer.
Lin A; Zhang J; Luo P
Front Immunol; 2020; 11():2039. PubMed ID: 32903444
[TBL] [Abstract][Full Text] [Related]
6. Clinical Significance and Prognostic Relevance of Microsatellite Instability in Sporadic Colorectal Cancer Patients.
Copija A; Waniczek D; Witkoś A; Walkiewicz K; Nowakowska-Zajdel E
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28067827
[TBL] [Abstract][Full Text] [Related]
7. Microsatellite instability testing and its role in the management of colorectal cancer.
Kawakami H; Zaanan A; Sinicrope FA
Curr Treat Options Oncol; 2015 Jul; 16(7):30. PubMed ID: 26031544
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and predictive significance of microsatellite instability in stage II colorectal carcinoma: An 8-year study from a tertiary center in South India.
Paulose RR; Ail DA; Biradar S; Vasudevan A; Sundaram KR
Indian J Cancer; 2019; 56(4):302-308. PubMed ID: 31607697
[TBL] [Abstract][Full Text] [Related]
9. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.
Marginean EC; Melosky B
Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791
[TBL] [Abstract][Full Text] [Related]
10. Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal Cancer.
Chen MH; Chang SC; Lin PC; Yang SH; Lin CC; Lan YT; Lin HH; Lin CH; Lai JI; Liang WY; Lu ML; Yang MH; Chao Y
Oncologist; 2019 Dec; 24(12):1534-1542. PubMed ID: 31292272
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of CD133 based on microsatellite instability status in human colorectal cancer.
Park JJ; Kwon JH; Oh SH; Choi J; Moon CM; Ahn JB; Hong SP; Cheon JH; Kim TI; Kim H; Kim WH
Mol Carcinog; 2014 Feb; 53 Suppl 1():E1-10. PubMed ID: 23065858
[TBL] [Abstract][Full Text] [Related]
12. Outcomes for Metastatic Colorectal Cancer Based on Microsatellite Instability: Results from the South Australian Metastatic Colorectal Cancer Registry.
Chong LC; Townsend AR; Young J; Roy A; Piantadosi C; Hardingham JE; Roder D; Karapetis C; Padbury R; Maddern G; Moore J; Price TJ
Target Oncol; 2019 Feb; 14(1):85-91. PubMed ID: 30659494
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of Mismatch Repair Status and Microsatellite Instability between Primary Tumour and Metastasis and Its Implications for Immunotherapy in Colorectal Cancers.
Evrard C; Messina S; Sefrioui D; Frouin É; Auriault ML; Chautard R; Zaanan A; Jaffrelot M; De La Fouchardière C; Aparicio T; Coriat R; Godet J; Silvain C; Randrian V; Sabourin JC; Guimbaud R; Miquelestorena-Standley E; Lecomte T; Moulin V; Karayan-Tapon L; Tachon G; Tougeron D
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457245
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of programmed cell death-ligand 1 expression and the immune microenvironment at the invasive front of colorectal cancers with high microsatellite instability.
Korehisa S; Oki E; Iimori M; Nakaji Y; Shimokawa M; Saeki H; Okano S; Oda Y; Maehara Y
Int J Cancer; 2018 Feb; 142(4):822-832. PubMed ID: 29044503
[TBL] [Abstract][Full Text] [Related]
15. Role of the cGAS-STING pathway in regulating the tumor-immune microenvironment in dMMR/MSI colorectal cancer.
Kaneta A; Nakajima S; Okayama H; Matsumoto T; Saito K; Kikuchi T; Endo E; Ito M; Mimura K; Kanke Y; Saito M; Saze Z; Fujita S; Sakamoto W; Onozawa H; Momma T; Ohki S; Kono K
Cancer Immunol Immunother; 2022 Nov; 71(11):2765-2776. PubMed ID: 35429245
[TBL] [Abstract][Full Text] [Related]
16. Expression of human leukocyte antigen class I and β2-microglobulin in colorectal cancer and its prognostic impact.
Na HY; Park Y; Nam SK; Lee KS; Oh HK; Kim DW; Kang SB; Kim WH; Lee HS
Cancer Sci; 2021 Jan; 112(1):91-100. PubMed ID: 33159376
[TBL] [Abstract][Full Text] [Related]
17. Investigation of ENO2 as a promising novel marker for the progression of colorectal cancer with microsatellite instability-high.
Cai J; Yang Y; Zhang L; Fang Y; Zhang Y; Tan M; Zhang J; Tang C; Ren H; Wang L; Xiang G; Xu F; Lan L; Li L; Zheng X
BMC Cancer; 2024 May; 24(1):573. PubMed ID: 38724951
[TBL] [Abstract][Full Text] [Related]
18. Molecular genetics of microsatellite-unstable colorectal cancer for pathologists.
Chen W; Swanson BJ; Frankel WL
Diagn Pathol; 2017 Mar; 12(1):24. PubMed ID: 28259170
[TBL] [Abstract][Full Text] [Related]
19. Reduced FHIT expression is associated with mismatch repair deficient and high CpG island methylator phenotype colorectal cancer.
Al-Temaimi RA; Jacob S; Al-Ali W; Thomas DA; Al-Mulla F
J Histochem Cytochem; 2013 Sep; 61(9):627-38. PubMed ID: 23797051
[TBL] [Abstract][Full Text] [Related]
20. Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer.
Zaravinos A; Roufas C; Nagara M; de Lucas Moreno B; Oblovatskaya M; Efstathiades C; Dimopoulos C; Ayiomamitis GD
J Exp Clin Cancer Res; 2019 Aug; 38(1):364. PubMed ID: 31429779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
